1 – 10 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Long-term effects of cholinesterase inhibitors and memantine on cognitive decline, cardiovascular events, and mortality in dementia with Lewy bodies : An up to 10-year follow-up study
(
- Contribution to journal › Article
- 2022
-
Mark
Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease
(
- Contribution to journal › Article
- 2021
-
Mark
Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease
(
- Contribution to journal › Article
- 2020
-
Mark
Tau PET and relative cerebral blood flow in dementia with Lewy bodies : A PET study
(
- Contribution to journal › Article
- 2019
-
Mark
A comprehensive screening of copy number variability in dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease
(
- Contribution to journal › Article
- 2018
-
Mark
Apolipoprotein E genotypes and longevity across dementia disorders
(
- Contribution to journal › Article
-
Mark
Living with Lewy body dementia. Treatment, survival & quality of life.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies : A cross-sectional study in 40 nursing homes in Sweden
(
- Contribution to journal › Article
- 2017
-
Mark
Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort
(
- Contribution to journal › Article